Viewpoints in dermatology ● Correspondence
Bimatoprost in vitiligo
A. K. Jha,
A. K. Jha
Department of Dermatology, STD and Leprosy, All India Institute Of Medical Sciences, Patna, Bihar, India
Search for more papers by this author R. Sinha,
R. Sinha
Department of Dermatology, STD and Leprosy, All India Institute Of Medical Sciences, Patna, Bihar, India
Search for more papers by this author
A. K. Jha,
A. K. Jha
Department of Dermatology, STD and Leprosy, All India Institute Of Medical Sciences, Patna, Bihar, India
Search for more papers by this author R. Sinha,
R. Sinha
Department of Dermatology, STD and Leprosy, All India Institute Of Medical Sciences, Patna, Bihar, India
Search for more papers by this author
First published: 23 September 2016
No abstract is available for this article.
References
- 1Smith S, Fagien S, Whitcup SM et al. Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study. J Am Acad Dermatol 2012; 66: 801–6.
- 2Scott G, Leopardi S, Printup S et al. Proteinase activated receptor-2 stimulates prostaglandin production in keratinocytes: analysis of prostaglandin receptors on human melanocytes and effects of PGE and PGF on melanocyte dendricity. J Invest Dermatol 2004; 122: 1214–24.
- 3Jha AK, Sinha R, Prasad S, Nandan N. Bimatoprost in periorbital vitiligo: a ray of hope or dilemma. J Eur Acad Dermatol Venereol 2016; 30: 1247–8.
- 4Bikowski J, Lau EG, Jacob SE. Eyelash growth: a beneficial side effect of prostaglandin analogues. Cutis 2010; 85: 187–8.
- 5Noh S, Kim TG, Oh SH. Three cases of vitiligo showing response to application of latanoprost. Korean J Dermatol 2010; 48: 350–3.
